Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polymyalgia rheumatica and giant cell arteritis. Avoiding management traps.

J P de Jager1

  • 1Gold Coast Hospital, Southport, Queensland.

Australian Family Physician
|September 18, 2001
PubMed
Summary

Polymyalgia rheumatica (PMR) is a common inflammatory condition in older adults, often presenting with pain and stiffness. Early recognition and appropriate corticosteroid management are crucial to minimize treatment toxicity and prevent complications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erythema multiforme with tumour necrosis factor inhibitors: a class effect?

Annals of the rheumatic diseases·2008
Same author

Retinal dystrophy in long chain 3-hydroxy-acyl-coA dehydrogenase deficiency.

The British journal of ophthalmology·1997
Same author

Problems with the shoulder, knee, ankle and foot.

The Medical journal of Australia·1996
Same author

3-Hydroxydicarboxylic aciduria due to long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency associated with sudden neonatal death: protective effect of medium-chain triglyceride treatment.

European journal of pediatrics·1991
Same author

Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: identification of a new inborn error of mitochondrial fatty acid beta-oxidation.

Journal of inherited metabolic disease·1990
Same author

Sudden infant death and long-chain 3-hydroxyacyl-CoA dehydrogenase.

Lancet (London, England)·1989

Area of Science:

  • Rheumatology
  • Internal Medicine

Background:

  • Polymyalgia rheumatica (PMR) is a significant condition in patients over 55, characterized by pain and stiffness.
  • PMR exists on a spectrum with giant cell arteritis (GCA), presenting diagnostic challenges.
  • Corticosteroid toxicity is a major concern due to improper dosing or prolonged treatment duration.

Observation:

  • Diagnosis of PMR relies on clinical presentation, symptoms, signs, and inflammatory markers.
  • Exclusion of alternative diagnoses is essential due to nonspecific inflammatory markers.
  • High-resolution ultrasound of temporal arteries can aid in directing temporal artery biopsies.

Findings:

  • No definitive diagnostic test exists for PMR, necessitating clinical diagnosis.
  • Serological markers of inflammation are nonspecific, requiring careful differential diagnosis.

Related Experiment Videos

  • Treatment response monitoring is critical; prolonged or unusual responses warrant re-evaluation.

    • Implications:

    • Accurate diagnosis and timely management of PMR are vital for patient outcomes.
    • Minimizing corticosteroid toxicity through appropriate dosing and preventive therapies (e.g., for osteoporosis) is paramount.
    • Understanding the PMR-GCA continuum aids in comprehensive patient care and diagnostic accuracy.